6CLADBA (6-CL-ADB-A)

Rated 5.00 out of 5 based on 2 customer ratings
(2 customer reviews)

5F-MDMB-2201 CAS 889493-21-2
2FDCK CAS 11982-50-4
ETIZOLAM ALPRAZOLAM CAS 40054-69-1
4FADB 5FADB CAS 1715016-75-3
Eutylone BK-EDBP ETHYLONE MDMA CAS 17764-18-0
U-48800 U-47700 CAS 67579-76-4
5cl-adb-a CAS 13605-48-6
Mfpep;
4-Amino-3,5-dichloroacetophenone;
4-Aminoacetophenone;
Carbomer 940;
BMK;
PMK

$140.00$3,800.00

Clear
Quantiy:

6CLADBA (6-CL-ADB-A) is a new synthetic cannabinoid, is an analogue of 5-CL-ADB-A and has a similar structure. 6CLADBA is a designer drug for chemical research and is currently legal in many countries. White or creamy white color, perfect potency and fragrance, welcome to order from 10g to 20kg shipping safe and fast

Synonyms6CLADBA  6-CL-ADB-A
IUPAC
Formula
Molecular weight
CAS
Appearancepowder
Purity≥ 98%

6CLADBA and all other synthetic cannabinoids sold on this site are for research and forensic applications.

Side effects from 6CLADBA are not known.

Keep this synthetic cannabinoid in a cool and dry place. Stability of cannabinoids 6CLADBA compounds up to 2 years with proper storage conditions.

 

Shipping via FEDEX USPS DHL and no extra fees required
Delivery time about 10-12 days
5F-MDMB-2201 CAS 889493-21-2
2FDCK CAS 11982-50-4
ETIZOLAM ALPRAZOLAM CAS 40054-69-1
4FADB 5FADB CAS 1715016-75-3
Eutylone BK-EDBP ETHYLONE MDMA CAS 17764-18-0
U-48800 U-47700 CAS 67579-76-4
5cl-adb-a CAS 13605-48-6
Mfpep;
4-Amino-3,5-dichloroacetophenone;
4-Aminoacetophenone;
Carbomer 940;
BMK;
PMK

 

Quick contact information

Wickr: submac2020

email: [email protected]

Telegram: @oneworld_s

Whatsapp : +3197005034294

 

Additional information

Quantity

1000g, 100g, 10g, 25g, 500g, 50g

2 reviews for 6CLADBA (6-CL-ADB-A)

  1. Rated 5 out of 5

    Paul Walker

    I am impressed bcoz I found what I wanted to buy at a low price. Thank you guys!

  2. Rated 5 out of 5

    Kenton

    I am impressed bcoz I found what I wanted to buy at a low price. Thank you guys

Add a review

Your email address will not be published. Required fields are marked *